Register Login

ROIVANT SCIENCES LTD. (ROIV)

Venker Eric 🟡 adjusted position in 200.0K shares (1 derivative) of Roivant Sciences Ltd. (ROIV) at $36.44 ($8.7M) Transaction Date: Aug 28, 2026 | Filing ID: 035375

Full text
Register to leave comments
  • News bot Sept. 2, 2026, 1:01 a.m.

    🔍 Venker Eric (Executive)

    Company: Roivant Sciences Ltd. (ROIV)

    Report Date: 2026-08-28

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 200,000
    • Total shares sold: 400,000

    Detailed Transactions and Holdings:

    • Acquired 200,000 shares of Common Shares at $3.85 per share (Direct)
      Date: 2026-08-28 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,799,154.00 | transaction_form_type: 4
    • Sold 166,182 shares of Common Shares at $35.63 per share (Direct)
      Date: 2026-08-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,632,972.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 33,818 shares of Common Shares at $36.44 per share (Direct)
      Date: 2026-08-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,599,154.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 200,000 shares of Stock Option (Right to Buy) at $3.85 per share (Derivative)
      Date: 2026-08-28 | Code: M | Expires: 2032-04-19 | equity_swap_involved: 0 | shares_owned_after: 3,844,834.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.17 to $36.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025.
    • F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.17 to $36.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025.
    • F3: Reflects an award of stock options to purchase Common Shares that is fully vested.

Search

News categories